Krishna District, India

Kavitha Nerella

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2012-2015.

USPTO Granted Patents = 2 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kavitha Nerella: Innovator in Pharmaceutical Processes

Introduction

Kavitha Nerella is a prominent inventor based in Krishna District, India. She has made significant contributions to the field of pharmaceuticals, particularly in the preparation of important medications. With a total of 2 patents to her name, her work has had a notable impact on the industry.

Latest Patents

Kavitha's latest patents focus on the processes for the preparation of sitagliptin and its pharmaceutically acceptable salts. One of her patents describes a method for the preparation of sitagliptin by deprotection of a specific compound. Another patent presents an improved process for the preparation of sitagliptin through the reduction of a compound followed by deprotection to yield the final product.

Career Highlights

Kavitha is currently employed at Dr. Reddy's Laboratories, Incorporated, where she continues to innovate and develop pharmaceutical processes. Her expertise in this area has positioned her as a valuable asset to her team and the company.

Collaborations

Throughout her career, Kavitha has collaborated with notable colleagues, including Pratap Reddy Padi and Babu Ireni. These collaborations have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Kavitha Nerella's contributions to pharmaceutical innovations demonstrate her commitment to advancing medical science. Her patents and work at Dr. Reddy's Laboratories highlight her role as a key inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…